BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31629517)

  • 1. Short communication: Determination of the milk pharmacokinetics and depletion of milk residues of flunixin following transdermal administration to lactating Holstein cows.
    Gorden PJ; Kleinhenz MD; Warner R; Sidhu PK; Coetzee JF
    J Dairy Sci; 2019 Dec; 102(12):11465-11469. PubMed ID: 31629517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of transdermal flunixin in lactating dairy goats.
    Meira EBS; Wiloch EE; Nixon E; Yeatts JL; Sheela FF; Smith GW; Baynes RE
    J Dairy Sci; 2022 Jan; 105(1):549-559. PubMed ID: 34656343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residue depletion study and withdrawal period for flunixin-N-methyl glucamine in bovine milk following intravenous administration.
    Ngoh MA; Wislocki PG; Thompson K; Katz T; Weingarten A; TerHune T; Hurshman B
    J Agric Food Chem; 2003 Jul; 51(16):4701-7. PubMed ID: 14705899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma pharmacokinetics and milk residues of flunixin and 5-hydroxy flunixin following different routes of administration in dairy cattle.
    Kissell LW; Smith GW; Leavens TL; Baynes RE; Wu H; Riviere JE
    J Dairy Sci; 2012 Dec; 95(12):7151-7. PubMed ID: 23040013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of multiple doses of transdermal flunixin meglumine in adult Holstein dairy cows.
    Kleinhenz MD; Gorden PJ; Smith JS; Schleining JA; Kleinhenz KE; Wulf LL; Sidhu PK; Rea D; Coetzee JF
    J Vet Pharmacol Ther; 2018 Jun; 41(3):490-493. PubMed ID: 29460288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excretory, Secretory, and Tissue Residues after Label and Extra-label Administration of Flunixin Meglumine to Saline- or Lipopolysaccharide-Exposed Dairy Cows.
    Smith DJ; Shelver WL; Baynes RE; Tell L; Gehring R; Li M; Dutko T; Schroeder JW; Herges G; Riviere JE
    J Agric Food Chem; 2015 May; 63(19):4893-901. PubMed ID: 25950946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pharmacokinetics and milk elimination of flunixin in healthy cows and cows with mastitis.
    Kissell LW; Leavens TL; Baynes RE; Riviere JE; Smith GW
    J Am Vet Med Assoc; 2015 Jan; 246(1):118-25. PubMed ID: 25517334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of transdermal flunixin meglumine on experimentally induced lameness in adult dairy cattle.
    Kleinhenz MD; Gorden PJ; Smith JS; Schleining JA; Kleinhenz KE; Juarez JR; Rea D; Coetzee JF
    J Dairy Sci; 2019 Jul; 102(7):6418-6430. PubMed ID: 31030917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age on the pharmacokinetics and pharmacodynamics of flunixin meglumine following intravenous and transdermal administration to Holstein calves.
    Kleinhenz MD; Van Engen NK; Gorden PJ; Smith JS; KuKanich B; Rajewski SM; Walsh P; Perkins S; Coetzee JF
    Am J Vet Res; 2018 May; 79(5):568-575. PubMed ID: 29688783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of transdermal flunixin meglumine in Holstein calves.
    Kleinhenz MD; Van Engen NK; Gorden PJ; KuKanich B; Rajewski SM; Walsh P; Coetzee JF
    J Vet Pharmacol Ther; 2016 Dec; 39(6):612-615. PubMed ID: 27121728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flunixin residues in milk after intravenous treatment of dairy cattle with (14)C-flunixin.
    Feely WF; Chester-Yansen C; Thompson K; Campbell JW; Boner PL; Liu DD; Crouch LS
    J Agric Food Chem; 2002 Dec; 50(25):7308-13. PubMed ID: 12452650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of flunixin glucuronide and depletion of flunixin and its marker residue in bovine milk.
    Jedziniak P; Olejnik M; Szprengier-Juszkiewicz T; Smulski S; Kaczmarowski M; Żmudzki J
    J Vet Pharmacol Ther; 2013 Dec; 36(6):571-5. PubMed ID: 23398483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ABCG2 in Secretion into Milk of the Anti-Inflammatory Flunixin and Its Main Metabolite: In Vitro-In Vivo Correlation in Mice and Cows.
    Garcia-Mateos D; Garcia-Lino AM; Alvarez-Fernandez I; Blanco-Paniagua E; de la Fuente A; Alvarez AI; Merino G
    Drug Metab Dispos; 2019 May; 47(5):516-524. PubMed ID: 30858238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis.
    Rantala M; Kaartinen L; Välimäki E; Stryrman M; Hiekkaranta M; Niemi A; Saari L; Pyörälä S
    J Vet Pharmacol Ther; 2002 Aug; 25(4):251-8. PubMed ID: 12213112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and Confirmatory Analyses of Flunixin in Tissues and Bodily Fluids after Intravenous or Intramuscular Administration to Cull Dairy Cows with or without Lipopolysaccharide Challenge.
    Shelver WL; Smith DJ; Tell LA; Baynes RE; Schroeder JW; Riviere JE
    J Agric Food Chem; 2016 Jan; 64(1):336-45. PubMed ID: 26695354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a rapid lateral flow test for the simultaneous determination of β-lactam drugs and flunixin in raw milk.
    Douglas D; Banaszewski K; Juskelis R; Al-Taher F; Chen Y; Cappozzo J; McRobbie L; Salter RS
    J Food Prot; 2012 Jul; 75(7):1270-7. PubMed ID: 22980011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of transdermal flunixin meglumine and effects on biomarkers of inflammation in horses.
    Knych HK; Arthur RM; Gretler SR; McKemie DS; Goldin S; Kass PH
    J Vet Pharmacol Ther; 2021 Sep; 44(5):745-753. PubMed ID: 34173263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a physiologically based pharmacokinetic model for flunixin in cattle (Bos taurus).
    Leavens TL; Tell LA; Kissell LW; Smith GW; Smith DJ; Wagner SA; Shelver WL; Wu H; Baynes RE; Riviere JE
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2014; 31(9):1506-21. PubMed ID: 25082521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short communication: Use of an ultrafiltration device in gland cistern for continuous sampling of healthy and mastitic quarters of lactating cattle for pharmacokinetic modeling.
    Mzyk DA; Bublitz CM; Sylvester H; Mullen KAE; Hobgood GD; Baynes RE; Foster DM
    J Dairy Sci; 2018 Nov; 101(11):10414-10420. PubMed ID: 30197136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of transdermal flunixin in sows.
    Cramer MC; Pairis-Garcia MD; Bowman AS; Moeller SJ; Zhang Y; Sidhu PK; Magnin G; Coetzee JF
    J Vet Pharmacol Ther; 2019 Jul; 42(4):492-495. PubMed ID: 31197844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.